Australia has confirmed its first human case of H5N1 bird flu, a grim milestone that means the virus has now been documented on every continent. The patient, a child who recently returned from overseas travel, is in a critical condition in a Melbourne hospital. Health officials say they are tracing contacts, but the source of exposure remains unclear.
This is not a pandemic. Not yet. But it is a warning shot. The H5N1 strain has been tearing through bird populations globally, with spillover into mammals raising alarms. The World Health Organisation has long warned that the virus could mutate to spread easily between humans. Each new case brings us closer to that edge.
The Australian government is downplaying the risk, as governments do. They say the public should not be alarmed. But sources inside the Department of Health confirm that contingency plans are being dusted off. Antiviral stockpiles are being audited. Vaccine contracts are being reviewed.
We should be asking questions. Who is profiting from this? Which pharmaceutical companies are positioned to supply vaccines and treatments? Which politicians hold shares in those companies? The pattern is always the same: a crisis emerges, panic spreads, public money flows to private hands. Then the crisis fades, the money stays, and no one is held accountable.
A quick look at the numbers: the global market for avian influenza vaccines was valued at over $1 billion before this latest surge. It will be higher now. Several companies have already announced expanded production capacity. GlaxoSmithKline, Sanofi, Seqirus. Follow the money.
The Australian case is also a test for the country's biosecurity systems. The child was diagnosed after returning from India. That raises questions about screening at airports. How many other cases have slipped through? The government says border measures are robust. But we have heard that before. During COVID, they said the quarantine system was watertight. It was not.
There is also the question of wild birds. H5N1 is now endemic in wild bird populations around the world. Migratory birds do not respect borders. Australia's wetlands are a stopover for thousands of birds from Asia. The virus will almost certainly reappear.
The child's family is under quarantine. Dozens of close contacts are being monitored. None have shown symptoms so far. That is good news. But the virus has a long incubation period. We will not know for days, possibly weeks, whether this is an isolated case or the beginning of a cluster.
What we do know is that the world is playing catch-up. The WHO's Global Influenza Programme has been underfunded for years. National pandemic preparedness plans are gathering dust. The same failures that allowed COVID to spread are being repeated.
This is not alarmism. It is realism. We have been warned. Again and again. The question is whether anyone is listening. Or whether we will wait until the bodies pile up before we act.
Sources in Melbourne's infectious disease units say the child is receiving experimental antiviral therapy. The family has asked for privacy. They are terrified. They should be. The rest of us should be paying attention.
I will be following the money. I will be digging into the contracts, the stockpiles, the profits. That is where the real story is. The virus is the trigger. The system is the target.
More as we have it.